Clinical trial
Intravitreal Dexamethasone Implant for Refractory Diabetic Macular Edema: Anatomical and Functional Outcomes of Treatment and Retreatment
NCT05847088 is registered in ClinicalTrials.gov with Dar El Oyoun Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intravitreal Dexamethasone Implant for Refractory Diabetic Macular Edema: Anatomical and Functional Outcomes of Treatment and Retreatment
- Lead sponsor
- Dar El Oyoun Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 15, 2023
- Completion date
- April 4, 2023
- Enrollment
- 58 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
diabetic macular edema